1. WHO. The European Mental Health Action Plan. «Europe- an Regional Committee, 63 session»; September 16–19,2013; Chetshe, Izmir, Turkey. (In Russ.). Available at: http://psychi-atr.ru/download/1862?name=63wd11r_MentalHealth-3.pd-f&view=1#page=30&zoom=auto,-98,814. Accessed October 6, 2017.
2. WHO. The European Mental Health Action Plan. «Problems and solutions: the WHO European Ministerial Conference on Mental Health»; January 12–15, 2005; Helsinki, Finland. (In Russ.). Available at: http://c2n.biz/registration/content/ua1725/pages/f38909. pdf#page=14&zoom=auto,-178,788. Accessed October 6, 2017.
3. Kendrick T., Stevens L., Bryant A., Goddard J., Stevens A., Raferty J., Thompson C. Hampshire Depression Project: changes in the process of care and cost consequences. Br. J. Gen. Pract. 2001;51:911–913.
4. Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann. Fam. Med. 2005;3(5):449–456.
5. MacGillivray S., Arroll B., Hatcher S., Ogston S., Reid I., Sullivan F., Williams B., Crombie I. Efcacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ. 2003;326(7397):1014.